Molecular characterization of paediatric idiopathic hypereosinophilia

British Journal of Haematology

Volumn 151, Issue 5, 2010, Pages 440-446

  Rapanotti, Maria Cristina ^a,b,c   Caruso, Roberta ^d   Ammatuna, Emanuele ^b,c   Zaza, Serena ^b,c   Trotta, Laura ^d   Divona, Mariadomenica ^b,c   Cicconi, Laura ^b   Funaro, Daria ^d   Federici, Giorgio ^a   Amadori, Sergio ^b   De Rossi, Giulio ^d   Lo Coco, Francesco ^b,c  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Childhood haematological malignancies; Clonality; Hypereosinophilia; Immunoglobulin heavy chain; Molecular diagnosis

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; IMATINIB; IMMUNOGLOBULIN HEAVY CHAIN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PREDNISONE; PROTEIN BCR ABL1; PROTEIN FIP1L1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; WT1 PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE FUSION; HUMAN; HYPEREOSINOPHILIC SYNDROME; KARYOTYPE; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; INFANT; LYMPHOMA, B-CELL; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 78349303018     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08394.x     Document Type: Article

References (43)

1. Aricò, M., Valsecchi, M.G., Rizzari, C., Barisone, E., Biondi, A., Casale, F., Locatelli, F., Lo Nigro, L., Luciani, M., Messina, C., Micalizzi, C., Parasole, R., Pession, A., Santoro, N., Testi, A.M., Silvestri, D., Basso, G., Masera, G. & Conter, V. (2008) Long-term results of the AIEOP-ALL-95 Tial for Chilhood Acute Lymphoblastic Leucemia: insight on the prognostic value of DNA index in the framework of Berlin-frankfurt-Muenster based chemotherapy. Journal of Clinical Oncology, 26, 83-89.
2. Bacher, U., Reiter, A., Haferlach, T., Mueller, L., Schnittger, S., Kern, W. & Schoch, C. (2006) A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia. Haematologica, 91, 817-820.
3. Bain, B. (2004) The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica, 89, 133-137.
4. Bain, B., Gilliland, D.G., Vardiman, J.W. & Horny, H.P. (2008) Chronic eosinophilic leukaemia, not otherwise specified. In: WHO Classification of Tumou+rs of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), Vol. 2, pp. 51-53, IARC Press, Lyon, France.
5. Bank, I., Amariglio, N., Reshef, A., Hardan, I., Confino, Y., Trau, H., Shtrasburg, S., Langevitz, P., Monselise, Y., Shalit, M. & Rechavi, G. (2001) The hypereosinophilic syndrome associated with CD4 + CD3- helper type 2 (Th2) lymphocytes. Leukaemia & Lymphoma, 42, 123-133.
6. Bernasconi, C. (2001) Hypereosinophilia in acute lymphoblastic leukemia: an association to be remembered. Haematologica, 86, 893.
7. Bhatti, F.A., Hussain, I. & Ali, M.Z. (2009) Adult B lymphoblastic leukaemia/lymphoma with hypodiploidy (-9) and a novel chromosomal translocation t(7;12)(q22;p13) presenting with severe eosinophilia - case report and review of literature. Journal of Hematology & Oncology, 2, 26.
8. Blatt, J., Proujansky, R., Horn, M., Phebus, C., Longworth, D. & Penchansky, L. (1992) Idiopathic hypereosinophilic syndrome terminating in acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 9, 151-155.
9. Brito-Bapapulle, F. (2003) The eosinophilias, including the Idiopathic Hypereosinophilic Syndrome. British Journal of Haematology, 121, 203-223.
10. Cave, H., Guidal, C., Rohrlich, P., Delfau, M.H., Broyart, A., Lescoeur, B., Rahimy, C., Fenneteau, O., Monplaisir, N., D'Auriol, L., Elion, J., Vilmer, E. & Grandchamp, B. (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood, 83, 1892-1902.
11. Chien, A.J., Argenyi, Z.B., Colven, R.M. & Kirby, P. (2004) Acute lymphoblastic leukemia presenting with urticarial plaques and hypereosinophilia in a child. Journal of the American Academy of Dermatology, 51, S151-S155.
12. Chusid, M.J., Dale, D.C., West, B.C. & Wolff, S.M. (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore), 54, 1-27.
13. Cilloni, D., Messa, F., Martinelli, G., Gottardi, E., Arruga, F., Defilippi, I., Carturan, S., Messa, E., Fava, M., Giugliano, E., Rosso, V., Catalano, R., Merante, S., Nicoli, P., Rondoni, M., Ottaviani, E., Soverini, S., Tiribelli, M., Pane, F., Baccarani, M. & Saglio, G. (2007) WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. Leukemia, 21, 1442-1450.
14. Cogan, E., Schandene, L., Crusiaux, A., Cochaux, P., Velu, T. & Goldman, M. (1994) Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. New England Journal of Medicine, 330, 535-538.
15. Conter, V., Aricò, M., Basso, G., Biondi, A., Barisone, E., Messina, C., Parasole, R., De Rossi, G., Locatelli, F., Pession, A., Santoro, N., Micalizzi, C., Citterio, M., Rizzari, C., Silvestri, D., Rondelli, R., Lo Nigro, L., Ziino, O., Testi, A.M., Masera, G., Valsecch, M.G.; Associazione Italiana di Ematologia ed Oncologia Pediatrica (2010) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82.85, 88, 91, and 95 for childhood acute lymphoblastic leukemia. Leukemia, 24, 255-264.
16. Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J.D., Cross, N.C., Tefferi, A., Malone, J., Alam, R., Schrier, S.L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantarjian, H., Marynen, P., Coutre, S.E., Stone, R. & Gilliland, D.G. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine, 348, 1201-1214.
17. D'Angelo, G., Hotz, A.M. & Todeschin, P. (2008) Acute lymphoblastic leukemia with hypereosinophilia and 9p21 deletion: case report and review of the literature. Laboratory Hematology, 14, 7-9.
18. Diss, T.C., Peng, H., Wotherspoon, A.C., Isaacson, P.G. & Pan, L. (1993) Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. Journal of Pathology, 169, 291-295.
19. Van Dongen, J.J., Macintyre, E.A., Gabert, J.A., Delabesse, E., Rossi, V., Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., Parreira, A., Gameiro, P., Diaz, M.G., Malec, M., Langerak, A.W., San Miguel, J.F. & Biondi, A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 1901-1928.
20. Farruggia, P., D'Angelo, P., Acquaviva, A., Trizzino, A., Tucci, F., Cilloni, D., Messa, F., D'Ambrosio, A. & Arico, M. (2009) Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases. Pediatric Hematology and Oncology, 26, 129-135.
21. Gleich, G.J. & Leiferman, K.M. (2009) The hypereosinophilic syndromes:current concepts and treatments. British Journal of Haematology, 145, 271-285.
22. Gotlib, J., Cools, J., Malone, J.M. 3rd, Schrier, S.L., Gilliland, D.G. & Coutre, S.E. (2004) The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood, 103, 2879-2891.
23. Helbig, G., Stella-Holowiecka, B., Majewski, M., Calbecka, M., Gajkowska, J., Klimkiewicz, R., Moskwa, A., Grzegorczyk, J., Lewandowska, M. & Holowiecki, J. (2008) A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. British Journal of Haematology, 141, 200-204.
24. Hill, A. & Metry, D. (2003) Urticarial lesions in a child with acute lymphoblastic leukemia and eosinophilia. Pediatric Dermatology, 20, 502-505.
25. Horigome, H., Sumazaki, R., Iwasaki, N., Imoto, N., Kinugasa, H., Saito, M. & Matsui, A. (2005) Fatal eosinophilic heart disease in a child with neurofibromatosis-1 complicated by acute lymphoblastic leukemia. Heart and Vessels, 20, 120-122.
26. Jain, P., Kumar, R., Gujral, S., Kumar, A., Singh, A., Jain, Y., Dubey, S., Anand, M. & Arya, L.S. (2000) Granular acute lymphoblastic leukemia with hypereosinophilic syndrome. Annals of Hematology, 79, 272-274.
27. Klion, A.D., Bochner, B.S., Gleich, G.J., Nutman, T.B., Rothenberg, M.E., Simon, H.U., Wechsler, M.E., Weller, P.F. & The Hypereosinophilic Syndromes Working, G. (2006) Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. Journal of Allergy and Clinical Immunology, 117, 1292-1302.
28. Meeker, T.C., Hardy, D., Willman, C., Hogan, T. & Abrams, J. (1990) Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood, 76, 285-289.
29. Nizet, Y., Martiat, P., Vaerman, J.L., Philippe, M., Wildmann, C., Staelens, J.P., Cornu, G., Ferrant, A., Michaux, J.L. & Sokal, G. (1991) Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. British Journal of Haematology, 79, 205-210.
30. Raghavachar, A., Fleischer, S., Frickhofen, N., Heimpel, H. & Fleischer, B. (1987) T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome. Journal Of Immunology, 139, 3753-3758.
31. Rapanotti, M.C., Caruso, R., Bernardini, S., Coletti, V., Lo-Coco, F. & De Rossi, G. (2005) Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma. Leukemia Research, 29, 975-979.
32. Rives, S., Alcorta, I., Toll, T., Tuset, E., Estella, J. & Cross, N.C. (2005) Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. Journal of Pediatric Hematology/Oncology, 27, 663-665.
33. Roche-Lestienne, C., Lepers, S., Soenen-Cornu, V., Kahn, J.E., Lai, J.L., Hachulla, E., Drupt, F., Demarty, A.L., Roumier, A.S., Gardembas, M., Dib, M., Philippe, N., Cambier, N., Barete, S., Libersa, C., Bletry, O., Hatron, P.Y., Quesnel, B., Rose, C., Maloum, K., Blanchet, O., Fenaux, P., Prin, L. & Preudhomme, C. (2005) Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia, 19, 792-798.
34. Roufosse, F., Schandene, L., Sibille, C., Willard-Gallo, K., Kennes, B., Efira, A., Goldman, M. & Cogan, E. (2000) Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. British Journal of Haematology, 109, 540-548.
35. Roumier, A.S., Grardel, N., Lai, J.L., Becqueriaux, I., Ghomari, K., De Lavareille, A., Roufosse, F., Prin, L. & Capron, M. (2003) Hypereosinophilia with abnormal T cells, trisomy 7 and elevated TARC serum level. Haematologica, 88, ECR24.
36. Salem, Z., Zalloua, P.A., Chehal, A., Bitar, N., Abboud, M., Kadri, A., Chami, B. & Bazarbachi, A. (2003) Effective treatment of hypereosinophilic syndrome with imatinib mesylate. The Hematology Journal, 4, 410-412.
37. Scheinfeld, N. (2003) Fatal fulminant hypereosinophilic syndrome with a petechial rash in a 16-year-old girl. Journal of Pediatric Hematology/Oncology, 25, 827-830.
38. Smith, K.J., Jacobson, E., Hamza, S. & Skelton, H. (2004) Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses. Archives of Dermatology, 140, 584-588.
39. Spitzer, G. & Garson, O.M. (1973) Lymphoblastic leukemia with marked eosinophilia: a report of two cases. Blood, 42, 377-384.
40. Swerdlov S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J. & Vardiman J.W., editors. (2008) WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues, 4th edn. pp. 109-138, IARC Press, Lyon, France.
41. Tefferi, A., Elliott, M.A. & Pardanani, A. (2006) Atypical myeloproliferative disorders: diagnosis and management. Mayo Clinic Proceedings, 81, 553-563.
42. Urtasùn, J.A., Izquierdo, A.Y., Barroso, B.R. & Huerta, A.S. (2001) Hipereosinophilia mantenida que precede al diagnostico de una leucemia linfoblastica aguda. Medicina Clinica, 116, 38-39.
43. Wynn, T.T., Heerema, N.A., Hammond, S., Ranalli, M. & Kahwash, S.B. (2003) Acute lymphoblastic leukemia with hypereosinophilia: report of a case with 5q deletion and review of the literature. Pediatric and Developmental Pathology, 6, 558-563.